SGLT2 blockers in T2DM

被引：1
|
作者：
Barranco, Caroline
机构：
来源：
NATURE REVIEWS CARDIOLOGY | 2018年 / 15卷 / 05期
关键词：
D O I：
10.1038/nrcardio.2018.35
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：255 / 255
页数：1
相关论文
共 50 条
  • [1] SGLT2 blockers in T2DM
    Caroline Barranco
    [J]. Nature Reviews Cardiology, 2018, 15 : 255 - 255
  • [2] SGLT2 inhibitors in people with and without T2DM
    Khunti, Kamlesh
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (02) : 75 - 76
  • [3] THE ROLE OF SGLT2 INHIBITORS IN THE MANAGEMENT OF T2DM
    Jung, Chang Hee
    [J]. JOURNAL OF HYPERTENSION, 2016, 34 : E186 - E186
  • [4] SGLT2 inhibitors in people with and without T2DM
    Kamlesh Khunti
    [J]. Nature Reviews Endocrinology, 2021, 17 : 75 - 76
  • [5] Survey to Specify SGLT2 Inhibitor Choice in T2DM Management
    Ghosal, Samit
    Joshi, Radhika M.
    Iyer, Rahul N.
    Adsule, Samir M.
    [J]. CLINICAL DIABETOLOGY, 2022, 11 (05): : 326 - 332
  • [6] Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology
    Wang, Anzhu
    Li, Zhendong
    Zhuo, Sun
    Gao, Feng
    Zhang, Hongwei
    Zhang, Zhibo
    Ren, Gaocan
    Ma, Xiaochang
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [7] The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
    Berezin, Alexander A.
    Fushtey, Ivan M.
    Berezin, Alexander E.
    [J]. BIOMEDICINES, 2022, 10 (07)
  • [8] Meta-Analysis on the Safety and Cardiorenal Efficacy of SGLT2 Inhibitors in Patients Without T2DM
    Li, Lu-Feng
    Ding, Liang-Liang
    Zhan, Ze-Lin
    Qiu, Mei
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [9] SGLT2 inhibitors attenuate alterations of kidney metabolic pathways in youth-onset T2DM
    Ellen F. Carney
    [J]. Nature Reviews Nephrology, 2023, 19 : 213 - 213
  • [10] SGLT2 inhibitors attenuate alterations of kidney metabolic pathways in youth-onset T2DM
    Carney, Ellen F.
    [J]. NATURE REVIEWS NEPHROLOGY, 2023, 19 (04) : 213 - 213
12345